Literature DB >> 27082509

Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions.

Alexandru Movila1, Takenobu Ishii1,2, Abdullah Albassam1,3,4, Wichaya Wisitrasameewong1,3,5, Mohammed Howait1,4, Tsuguno Yamaguchi1,6, Montserrat Ruiz-Torruella1, Laila Bahammam4, Kazuaki Nishimura1,7, Thomas Van Dyke1, Toshihisa Kawai1,3.   

Abstract

By binding to its chemokine receptor CXCR4 on osteoclast precursor cells (OCPs), it is well known that stromal cell-derived factor-1 (SDF-1) promotes the chemotactic recruitment of circulating OCPs to the homeostatic bone remodeling site. However, the engagement of circulating OCPs in pathogenic bone resorption remains to be elucidated. The present study investigated a possible chemoattractant role of macrophage migration inhibitory factor (MIF), another ligand for C-X-C chemokine receptor type 4 (CXCR4), in the recruitment of circulating OCPs to the bone lytic lesion. To accomplish this, we used Csf1r-eGFP-knock-in (KI) mice to establish an animal model of polymethylmethacrylate (PMMA) particle-induced calvarial osteolysis. In the circulating Csf1r-eGFP+ cells of healthy Csf1r-eGFP-KI mice, Csf1r+/CD11b+ cells showed a greater degree of RANKL-induced osteoclastogenesis compared to a subset of Csf1r+/RANK+ cells in vitro. Therefore, Csf1r-eGFP+/CD11b+ cells were targeted as functionally relevant OCPs in the present study. Although expression of the two cognate receptors for MIF, CXCR2 and CXCR4, was elevated on Csf1r+/CD11b+ cells, transmigration of OCPs toward recombinant MIF in vitro was facilitated by ligation with CXCR4, but not CXCR2. Meanwhile, the level of PMMA-induced bone resorption in calvaria was markedly greater in wild-type (WT) mice compared to that detected in MIF-knockout (KO) mice. Interestingly, in contrast to the elevated MIF, diminished SDF-1 was detected in a particle-induced bone lytic lesion of WT mice in conjunction with an increased number of infiltrating CXCR4+ OCPs. However, such diminished SDF-1 was not found in the PMMA-injected calvaria of MIF-KO mice. Furthermore, stimulation of osteoblasts with MIF in vitro suppressed their production of SDF-1, suggesting that MIF can downmodulate SDF-1 production in bone tissue. Systemically administered anti-MIF neutralizing monoclonal antibody (mAb) inhibited the homing of CXCR4+ OCPs, as well as bone resorption, in the PMMA-injected calvaria, while increasing locally produced SDF-1. Collectively, these data suggest that locally produced MIF in the inflammatory bone lytic site is engaged in the chemoattraction of circulating CXCR4+ OCPs.
© 2016 American Society for Bone and Mineral Research. © 2016 American Society for Bone and Mineral Research.

Entities:  

Keywords:  CXCR4; MIF; OSTEOCLAST PRECURSORS; PARTICLE-INDUCED OSTEOLYTIC LESIONS; SDF-1

Mesh:

Substances:

Year:  2016        PMID: 27082509      PMCID: PMC5010512          DOI: 10.1002/jbmr.2854

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  61 in total

1.  MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling.

Authors:  Christina Klasen; Kim Ohl; Marieke Sternkopf; Idit Shachar; Corinna Schmitz; Nicole Heussen; Elias Hobeika; Ella Levit-Zerdoun; Klaus Tenbrock; Michael Reth; Jürgen Bernhagen; Omar El Bounkari
Journal:  J Immunol       Date:  2014-04-23       Impact factor: 5.422

2.  Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids.

Authors:  L Santos; P Hall; C Metz; R Bucala; E F Morand
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

3.  Osteoblast isolation from murine calvaria and long bones.

Authors:  Astrid D Bakker; Jenneke Klein-Nulend
Journal:  Methods Mol Biol       Date:  2012

4.  Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone.

Authors:  Ted S Liao; Matthew B Yurgelun; Seong-Sil Chang; Hui-Zhu Zhang; Koko Murakami; Theodore A Blaine; May V Parisien; William Kim; Robert J Winchester; Francis Young-In Lee
Journal:  J Orthop Res       Date:  2005-01       Impact factor: 3.494

5.  Lineage-committed osteoclast precursors circulate in blood and settle down into bone.

Authors:  Akinori Muto; Toshihide Mizoguchi; Nobuyuki Udagawa; Susumu Ito; Ichiro Kawahara; Yoshimitsu Abiko; Atsushi Arai; Suguru Harada; Yasuhiro Kobayashi; Yuko Nakamichi; Josef M Penninger; Toshihide Noguchi; Naoyuki Takahashi
Journal:  J Bone Miner Res       Date:  2011-12       Impact factor: 6.741

6.  Transforming growth factor-beta1 down-regulates expression of chemokine stromal cell-derived factor-1: functional consequences in cell migration and adhesion.

Authors:  Natalia Wright; Teresa Laín de Lera; Carelia García-Moruja; Rosa Lillo; Félix García-Sánchez; Antonio Caruz; Joaquin Teixidó
Journal:  Blood       Date:  2003-05-29       Impact factor: 22.113

7.  The role of Mac-1 (CD11b/CD18) in osteoclast differentiation induced by receptor activator of nuclear factor-kappaB ligand.

Authors:  Hidetaka Hayashi; Ken-ichi Nakahama; Takahiro Sato; Takehiko Tuchiya; Yasuyuki Asakawa; Toshimitu Maemura; Masanobu Tanaka; Mineto Morita; Ikuo Morita
Journal:  FEBS Lett       Date:  2008-09-04       Impact factor: 4.124

8.  Cloning of the gene encoding the Actinobacillus actinomycetemcomitans serotype b OmpA-like outer membrane protein.

Authors:  H Komatsuzawa; T Kawai; M E Wilson; M A Taubman; M Sugai; H Suginaka
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

9.  AMD3100 improves ovariectomy-induced osteoporosis in mice by facilitating mobilization of hematopoietic stem/progenitor cells.

Authors:  Jin Young Im; Woo-Kie Min; Min Hee Park; NamOh Kim; Jong Kil Lee; Hee Kyung Jin; Je-Yong Choi; Shin-Yoon Kim; Jae-sung Bae
Journal:  BMB Rep       Date:  2014-08       Impact factor: 4.778

10.  The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor.

Authors:  T Calandra; J Bernhagen; R A Mitchell; R Bucala
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

View more
  12 in total

1.  Assessment of the involvement of the macrophage migration inhibitory factor-glucocorticoid regulatory dyad in the expression of matrix metalloproteinase-2 during periodontitis.

Authors:  Josefine Hirschfeld; Mohammed Howait; Alexandru Movila; Marijo Parčina; Isabelle Bekeredjian-Ding; James Deschner; Søren Jepsen; Toshihisa Kawai
Journal:  Eur J Oral Sci       Date:  2017-08-04       Impact factor: 2.612

2.  DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.

Authors:  W Wisitrasameewong; M Kajiya; A Movila; S Rittling; T Ishii; M Suzuki; S Matsuda; Y Mazda; M R Torruella; M M Azuma; K Egashira; M O Freire; H Sasaki; C Y Wang; X Han; M A Taubman; T Kawai
Journal:  J Dent Res       Date:  2017-02-15       Impact factor: 6.116

3.  Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factor.

Authors:  Hiroyuki Kanzaki; Alexandru Movila; Rayyan Kayal; Marcelo H Napimoga; Kenji Egashira; Floyd Dewhirst; Hajime Sasaki; Mohammed Howait; Ayman Al-Dharrab; Abdulghani Mira; Xiaozhe Han; Martin A Taubman; Frank C Nichols; Toshihisa Kawai
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-01-31       Impact factor: 4.698

4.  Elevated Expression of Macrophage Migration Inhibitory Factor Promotes Inflammatory Bone Resorption Induced in a Mouse Model of Periradicular Periodontitis.

Authors:  Mohammed Howait; Abdullah Albassam; Chiaki Yamada; Hajime Sasaki; Laila Bahammam; Mariane Maffei Azuma; Luciano Tavares Angelo Cintra; Abhay R Satoskar; Satoru Yamada; Robert White; Toshihisa Kawai; Alexandru Movila
Journal:  J Immunol       Date:  2019-02-08       Impact factor: 5.422

5.  OC-STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up-regulation of permissive fusogen CD9.

Authors:  Takenobu Ishii; Montserrat Ruiz-Torruella; Atsushi Ikeda; Satoru Shindo; Alexandru Movila; Hani Mawardi; Abdullah Albassam; Rayyan A Kayal; Ayman A Al-Dharrab; Kenji Egashira; Wichaya Wisitrasameewong; Kenta Yamamoto; Abdulghani I Mira; Kenji Sueishi; Xiaozhe Han; Martin A Taubman; Takeshi Miyamoto; Toshihisa Kawai
Journal:  FASEB J       Date:  2018-03-13       Impact factor: 5.191

6.  TRAP-positive osteoclast precursors mediate ROS/NO-dependent bactericidal activity via TLR4.

Authors:  Kazuaki Nishimura; Satoru Shindo; Alexandru Movila; Rayyan Kayal; Albassam Abdullah; Irma Josefina Savitri; Atsushi Ikeda; Tsuguno Yamaguchi; Mohammed Howait; Ayman Al-Dharrab; Abdulghani Mira; Xiaozhe Han; Toshihisa Kawai
Journal:  Free Radic Biol Med       Date:  2016-06-22       Impact factor: 7.376

Review 7.  Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.

Authors:  Wanli Yu; Sai Liang; Chunzhi Zhang
Journal:  Neuromolecular Med       Date:  2018-09-04       Impact factor: 3.843

8.  Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice.

Authors:  Silvia Marino; Daniëlle de Ridder; Ryan T Bishop; Nathalie Renema; Marco Ponzetti; Antonia Sophocleous; Mattia Capulli; Abdullah Aljeffery; Giovana Carrasco; Marianela Dalghi Gens; Asim Khogeer; Stuart H Ralston; Jürg Gertsch; Francois Lamoureux; Dominique Heymann; Nadia Rucci; Aymen I Idris
Journal:  EBioMedicine       Date:  2019-05-29       Impact factor: 8.143

9.  Effect of CD133 overexpression on bone metastasis in prostate cancer cell line LNCaP.

Authors:  Hong Moon Sohn; Bora Kim; Mineon Park; Young Jong Ko; Yeon Hee Moon; Jae Myung Sun; Byung-Cheol Jeong; Young Wook Kim; Wonbong Lim
Journal:  Oncol Lett       Date:  2019-06-06       Impact factor: 2.967

10.  Contribution of Porphyromonas gingivalis lipopolysaccharide to experimental periodontitis in relation to aging.

Authors:  Juliet Akkaoui; Chiaki Yamada; Carolina Duarte; Anny Ho; Saynur Vardar-Sengul; Toshihisa Kawai; Alexandru Movila
Journal:  Geroscience       Date:  2020-08-26       Impact factor: 7.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.